Clinical trial Recruiting at 1 site Interventional Ages 45 to 65 Women only

Nitrate and Exercise for vascular health in midlife women

Official title: Effects of Dietary Nitrate From Beetroot Juice on Vascular Function and Adaptations to Exercise Training in Postmenopausal Women: a Randomized, Placebo-controlled Study

Run by University of Vienna · NCT06527248 · Data updated 2026-11-12

This study tests whether daily beetroot juice (nitrate) plus regular aerobic exercise improves blood vessel function and blood pressure in postmenopausal women.

More Hypertension trials

Quick facts

Study typeInterventional
Ages45 Years to 65 Years
SexWomen only
Enrollment54 (estimated)
SponsorUniversity of Vienna
Academic / other
Locations1 site (Vienna, State of Vienna)
StatusRecruiting
StartedMarch 31, 2025
Main results expectedMarch 2027
Study endsMarch 2027
Registry record updatedJune 5, 2026
Trial IDNCT06527248 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Postmenopausal women aged 45–65 who are normotensive or have stage 1 hypertension and are not regularly exercising.

Probably not a fit

Individuals with high disease burden, very high fitness levels, or those unable to safely perform aerobic exercise may not experience added benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study will compare a nitrate-rich beetroot juice group with a placebo group, both undergoing an aerobic exercise program, to see if dietary nitrate enhances vascular function and physical performance. Participants are postmenopausal women aged 45–65, with or without treated stage 1 hypertension. The trial uses the nitrate-nitrite-NO pathway to potentially boost the vascular adaptations to exercise and reduce inflammation and oxidative stress. It aims to determine if the combination provides greater benefits than exercise alone. The study is led by the University of Vienna with collaborators in Vienna and Giessen.

Why it matters

Potential benefit: If successful, participants could experience greater improvements in vascular function, blood pressure control, and physical performance through a simple nutritional adjunct to exercise.

How similar studies have gone: Previous research suggests nitrate from vegetables can improve NO availability and exercise performance, supporting potential benefit for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Postmenopausal women (amenorrhoeic ≥1 year), between the ages of 45 and 65 years, inclusive, who are either normotensive or are medically treated for stage 1 hypertension
* Written informed consent

Exclusion Criteria:

* Current or recent (within previous 3 months) engagement in exercise training (i.e., planned, structured, and regular exercise) with an average net exercise time of \>2 hours per week
* Above-average cardiorespiratory fitness levels (i.e., a V̇O2 max max above the 75th percentile of age- and sex-specific normative data: ≥43 mL/kg/min for women aged 45-49 years, ≥38 mL/kg/min for women aged 50-59 years, ≥35 mL/kg/min for women aged 60-65 years)
* Any evidence of acute or chronic diseases such as symptomatic cardiovascular or peripheral vascular disease, moderate or severe chronic kidney disease (estimated glomerular filtration rate (GFR) \<50 mL/min), pulmonary, neural, or musculoskeletal disease, osteoporotic fractures, cancer, or type 1 or 2 diabetes mellitus
* Fasting glucose \>7.0 mmol/L or HbA1c \> 6.5 rel. %
* BMI \<18.5 kg/m2 or \>30kg/m2
* A mean 24-hour ambulatory systolic/diastolic blood pressure of ≥130/80 mm Hg
* Irregular resting electrocardiography (ECG)
* Inability to perform physical exercise
* Abnormal cardiovascular responses during the baseline V ̇O2 max test, including symptoms, ECG abnormalities, arrhythmias, or exaggerated blood pressure responses
* Current or recent (\<12 months) oestrogen-based hormone-replacement therapy
* Chronic use of nitric oxide (NO) donors, organic nitrites/nitrates, Ticagrelor, sodium-glucose cotransporter 2 (SGLT2) inhibitors, high-dose statins (i.e., Simvastatin \>40mg/day, Atorvastatin \>20mg/day, Rosuvastatin \>10mg/day), acetylsalicylic acid \>100mg/day, non-steroidal anti-inflammatory drugs (NSAID)
* A change in drug therapy likely to influence major outcomes within the previous 2 months, or likelihood that drug therapy would change during the study
* Use of antibiotics (within previous 2 months)
* Use of antibacterial mouthwash (volunteers willing to cease using antibacterial mouthwash for a period of 4 weeks before randomization will be included)
* Being vegan or vegetarian or consumption of \>5 serves of vegetables per day
* Current or recent (within previous 6 months) significant (\>6%) loss or gain of body weight
* Current or recent (\<12 months) regular smoking of \>5 cigarettes per day
* Alcohol intake of \>70 g per week and/or binge drinking behaviour
* Inability or unwillingness to follow the study protocol

Where it's running

  • University of Vienna
    Vienna, State of Vienna, Austria
    Recruiting

Study contacts

  • Principal investigator: Oliver Neubauer, Dr.Priv.Doz. — University of Vienna
  • Study coordinator: Oliver Neubauer, Dr.Priv.Doz.
  • Email: oliver.neubauer@univie.ac.at
  • Phone: +4314277

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.